M&T Bank Corp Astrazeneca PLC Transaction History
M&T Bank Corp
- $231 Billion
- Q4 2024
A detailed history of M&T Bank Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, M&T Bank Corp holds 243,178 shares of AZN stock, worth $19 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
243,178
Previous 251,109
3.16%
Holding current value
$19 Million
Previous $19.6 Million
18.57%
% of portfolio
0.01%
Previous 0.06%
Shares
33 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.71 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.2 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.92 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.89 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.87 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...